サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：埋込み型輸液ポンプ市場- 成長、将来展望、競合分析、2023年～2031年
市場調査レポート
商品コード
1313698

埋込み型輸液ポンプ市場- 成長、将来展望、競合分析、2023年～2031年

Implantable Infusion Pumps Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
埋込み型輸液ポンプ市場- 成長、将来展望、競合分析、2023年～2031年
出版日: 2023年06月19日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

埋込み型輸液ポンプ市場は2031年までに5.2%で成長する見込みで、埋込み型輸液ポンプは人体の特定部位に薬物を送達するために外科的に皮下に埋め込む小型デバイスであり、痛みを軽減するために標的を絞った一貫した薬物を提供します。埋込み型輸液ポンプ市場の需要拡大を支えている主な要因は、老人人口の増加、慢性疾患の蔓延、ヘルスケアサービスへのアクセス、民間病院の増加です。健康意識の向上により、先進国、発展途上国を問わず老年人口が増加しており、その結果、入院率が上昇し、インプラント手術の件数が増加しています。術後の疼痛管理を必要とする慢性疾患が広く蔓延していることも、埋込み型輸液ポンプ市場の成長に好影響を与えると思われます。ヘルスケア保険会社により、病気の患者がより良いヘルスケアサービスを利用できるようになっています。医療・福祉に巨額の支出を行う民間病院の増加と地方への拡大は、埋込み型輸液ポンプの市場浸透に好影響を与えます。しかし、このシナリオにおける課題は、薬物の禁断症状、インプラント部位の痛みと感染症、インプラントに関連する機械的な問題（ギアの停止、電池切れ）から生じる潜在的な合併症であり、重傷につながる可能性があります。埋込み型輸液ポンプ市場に関する抑制要因は、曖昧な償還、機器の複雑さによる頻繁な製品リコールです。曖昧な償還政策は、薬物インプラントのサービスを必要とする疾患に対する費用補償のサービス差別を引き起こし、ヘルスケア領域における支出の最大の障害となっています。ポンプの設計が複雑で、ドラッグデリバリーの不具合が繰り返されるため、製品リコールが頻発し、製品の研究開発に巨額の費用がかかります。これは埋込み型輸液ポンプ市場の浸透にマイナスの影響を与えています。

北米と欧州では、胃腸合併症、心血管疾患、糖尿病、がんなどの主要な慢性疾患が増加しており、疾患に対する意識が高く、低侵襲手術の需要が高まっているため、これらの地域での埋込み型輸液ポンプ市場の成長を後押しすると予想されます。ただし、大手企業による競合が激しく、製品回収の可能性や患者の安全性への悪影響を低減するため、設計やアプリケーションにおける画期的な技術革新が求められています。アジア太平洋と中東・アフリカは、即座の医療介入を必要とする慢性疾患の有病率が高いが、疾患に対する認識が低いため、潜在的な市場です。僻地や半都市部の未開拓市場を取り込むことができます。

Codman and Shurtleff（CODMAN 3000）のようなメーカーは、慢性疼痛治療のために一定流量のドラッグデリバリーを提供しています。Medtronics社は、持続グルコースモニタリング機能付きインスリンポンプを提供しています。埋込み型輸液ポンプ市場で観察される最新の製品は、浸透圧ポンプ（ALZET）、バルーンポンプ（Fresenius Kabi AG）です。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 埋込み型輸液ポンプ市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 vs 2031

第4章 埋込み型輸液ポンプ市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の埋込み型輸液ポンプ市場金額 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 埋込み型輸液ポンプ市場：製品別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 患者管理鎮痛（PCA）ポンプ
    • 経腸ポンプ
    • インスリンポンプ
    • エラストマーポンプ
    • シリンジポンプ

第6章 埋込み型輸液ポンプ市場：用途別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 腫瘍学
    • 小児科・新生児科
    • 消化器科
    • 血液学
    • 糖尿病

第7章 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 病院
    • 外来手術センター
    • クリニック
    • 在宅医療

第8章 北米の埋込み型輸液ポンプ市場 2021-2031

  • 市場概要
  • 埋込み型輸液ポンプ市場：製品別 2021-2031
  • 埋込み型輸液ポンプ市場：用途別 2021-2031
  • 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031
  • 埋込み型輸液ポンプ市場：地域別 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国と欧州連合の埋込み型輸液ポンプ市場 2021-2031

  • 市場概要
  • 埋込み型輸液ポンプ市場：製品別 2021-2031
  • 埋込み型輸液ポンプ市場：用途別 2021-2031
  • 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031
  • 埋込み型輸液ポンプ市場：地域別 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋の埋込み型輸液ポンプ市場 2021-2031

  • 市場概要
  • 埋込み型輸液ポンプ市場：製品別 2021-2031
  • 埋込み型輸液ポンプ市場：用途別 2021-2031
  • 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031
  • 埋込み型輸液ポンプ市場：地域別 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカの埋込み型輸液ポンプ市場 2021-2031

  • 市場概要
  • 埋込み型輸液ポンプ市場：製品別 2021-2031
  • 埋込み型輸液ポンプ市場：用途別 2021-2031
  • 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031
  • 埋込み型輸液ポンプ市場：地域別 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東・アフリカの埋込み型輸液ポンプ市場 2021-2031

  • 市場概要
  • 埋込み型輸液ポンプ市場：製品別 2021-2031
  • 埋込み型輸液ポンプ市場：用途別 2021-2031
  • 埋込み型輸液ポンプ市場：エンドユーザー別 2021-2031
  • 埋込み型輸液ポンプ市場：地域別 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Codman and Shurtleff
  • I-Flow Corp/Hylard Health
  • Flowobix Medical Inc.
  • Medtronic
  • Tricumed Medizintechnik GmbH.
  • B. Braun Melsungen AG.
  • CareFusion Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • Baxter International Inc.
  • Smiths Medical
  • MOOG Inc.
  • Johnson & Johnson Private Ltd.
  • Hospira Inc.
  • Flowonix
  • he Tandem Diabetes Care
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 4 North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 7 U.S. Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 10 Canada Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 19 UK Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 22 Germany Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 25 Spain Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 28 Italy Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 31 France Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 37 Asia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 40 China Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 43 Japan Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 46 India Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 49 Australia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 52 South Korea Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 55 Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 58 Brazil Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 61 Mexico Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 70 GCC Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 73 Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Implantable Infusion Pumps Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Implantable Infusion Pumps Market: Quality Assurance
  • FIG. 5 Global Implantable Infusion Pumps Market, By Product, 2022
  • FIG. 6 Global Implantable Infusion Pumps Market, By Application, 2022
  • FIG. 7 Global Implantable Infusion Pumps Market, By End User, 2022
  • FIG. 8 Global Implantable Infusion Pumps Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Implantable Infusion Pumps Market, 2022

FIG. 10Market Positioning of Key Implantable Infusion Pumps Market Players, 2022

FIG. 11Global Implantable Infusion Pumps Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Implantable Infusion Pumps Market, By Product, 2022 Vs 2031, %
  • FIG. 13 Global Implantable Infusion Pumps Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Implantable Infusion Pumps Market, By End User, 2022 Vs 2031, %
  • FIG. 15 U.S. Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 22 France Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 24 China Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 26 India Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
目次
Product Code: 137228-06-23

Implantable infusion pumps market expected to Grow at 5.2% by 2031, Implantable infusion pumps are compact devices that are surgically implanted under the skin to deliver drug to specific parts of the human body, they provide targeted and consistent medication to reduce pain. The major factorial entities supporting the growth in demand for implantable infusion pumps market are rise in geriatric population, wide prevalence of chronic diseases, access to healthcare services and rise in private sector hospitals. Due to better health awareness there has been rise in geriatric population in both the developed and developing nations as a result the rate of hospitalization has increased the number of implant surgeries. Wide prevalence of chronic diseases requiring post-operative pain management will have a positive impact on the growth of the implantable infusion pumps market. Healthcare insurance companies have made it possible for ailing patients to access to better healthcare services. Rise in private sector hospitals spending huge amount on health and welfare and its expansion to rural areas have a positive impact on the deep market penetration of implantable infusion pumps. However, the challenges in this scenario would be drug withdrawal symptoms, pain and infection at the implant site and potential complications arising because of mechanical problems related to implant (gear stopping, battery dying) would lead to serious injury. Restraints regarding the implantable infusion pumps market are ambiguous reimbursement, frequent product recalls due to complexity of the equipment. Ambiguous reimbursement policies cause service discrimination in the cost coverage for the diseases requiring drug implant services which is the biggest hurdle for the expenditure in the healthcare domain. The complexity in the design of the pump and repetitive failure in the drug delivery of the pumps leading to frequent product recalls have led to huge expenditure on the product R&D. This has a negative impact on the market penetration of implantable infusion pumps market.

In North America and Europe there is an increasing number of major chronic diseases like gastrointestinal complications, cardiovascular diseases, diabetes and cancer, high disease awareness and rising demand for minimally invasive surgery is expected to assist the growth of implantable infusion pumps market in these regions. The pitfall being high degree of competition by major players which urges need for path breaking innovation in design and application to reduce the probability of product recalls and adverse impact on patient safety. Asia-Pacific and Middle East and Africa are potential market due to high prevalence of chronic diseases requiring immediate medical intervention but less disease awareness. The untapped market in the remote and semi-urban areas can be captured.

Manufacturers like Codman and Shurtleff (CODMAN 3000) provides constant flow of drug delivery for treatment of chronic pain. Medtronics provides insulin pumps with continuous glucose monitoring. The latest products observed in the implantable infusion pump market are Osmotic pumps (ALZET), Balloon pumps (Fresenius Kabi AG) are employed for better results.

Key players identified for global implantable infusion pumps market include:

Codman and Shurtleff, I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., B. Braun Melsungen AG., CareFusion Corporation, Fresenius Kabi AG, Terumo Corporation, Baxter International Inc., Smiths Medical, MOOG Inc., Johnson & Johnson Private Ltd., and Hospira, Inc., Flowonix, The Tandem Diabetes Care And Other Notable Players.

This report offers:

  • An overview of the global implantable infusion pumps market.
  • Market trends assessment for the period 2015-2025, with historical information for 2015, and projections through 2025, with respective CAGRs during 2017-2025.
  • Qualitative assessment tools such as market drivers, challenges and future prospects.
  • Market competition scrutiny tools such as market share analysis, fractal map assessment.
  • Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics.
  • A general overview of the industry structure.
  • Company profiles highlighting key information about the major players operating in the global implantable infusion pumps market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofImplantable Infusion Pumps market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Implantable Infusion Pumps market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Patient-Controlled Analgesia (PCA) Pump
  • Enteral Pump
  • Insulin Pump
  • Elastomeric Pump
  • Syringe Pump

Application

  • Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes

End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics
  • Home Healthcare

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Implantable Infusion Pumps market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Implantable Infusion Pumps market?
  • Which is the largest regional market for Implantable Infusion Pumps market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Implantable Infusion Pumps market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Implantable Infusion Pumps market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Implantable Infusion Pumps Market
  • 2.2. Global Implantable Infusion Pumps Market, By Product, 2022 (US$ Million)
  • 2.3. Global Implantable Infusion Pumps Market, By Application, 2022 (US$ Million)
  • 2.4. Global Implantable Infusion Pumps Market, By End User, 2022 (US$ Million)
  • 2.5. Global Implantable Infusion Pumps Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Implantable Infusion Pumps Market: Competitive Analysis

  • 3.1. Market Positioning of Key Implantable Infusion Pumps Market Vendors
  • 3.2. Strategies Adopted by Implantable Infusion Pumps Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Implantable Infusion Pumps Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Implantable Infusion Pumps Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Patient-Controlled Analgesia (PCA) Pump
    • 5.3.2. Enteral Pump
    • 5.3.3. Insulin Pump
    • 5.3.4. Elastomeric Pump
    • 5.3.5. Syringe Pump

6. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Oncology
    • 6.3.2. Pediatrics/Neonatology
    • 6.3.3. Gastroenterology
    • 6.3.4. Hematology
    • 6.3.5. Diabetes

7. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centres
    • 7.3.3. Clinics
    • 7.3.4. Home Healthcare

8. North America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 8.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 8.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 8.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

9. UK and European Union Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 9.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 9.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 9.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

10. Asia Pacific Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 10.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 10.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 10.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

11. Latin America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 11.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 11.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 11.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

12. Middle East and Africa Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 12.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 12.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 12.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Codman and Shurtleff
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. I-Flow Corp/Hylard Health
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Flowobix Medical, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Medtronic
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Tricumed Medizintechnik GmbH.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. B. Braun Melsungen AG.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. CareFusion Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Fresenius Kabi AG
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Terumo Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Baxter International Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Smiths Medical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. MOOG Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Johnson & Johnson Private Ltd.
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. Hospira, Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Flowonix
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives
  • 13.16. he Tandem Diabetes Care
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Portfolio
    • 13.16.4. Strategic Initiatives
  • 13.17. Other Notable Players
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Portfolio
    • 13.17.4. Strategic Initiatives